The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5 , Pages 1234-1240.e1 , May 2009

Matching donor to recipient in lung transplantation: How much does size matter?

  • David P. Mason, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
    • Corresponding Author InformationAddress for reprints: David P. Mason, MD, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Avenue/Desk J4-1, Cleveland, OH 44195.
  • ,
  • Lillian H. Batizy, MS

      Affiliations

    • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Jeffrey Wu, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Edward R. Nowicki, MD, MS

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Sudish C. Murthy, MD, PhD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Ann M. McNeill, RN

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Marie M. Budev, DO

      Affiliations

    • Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Atul C. Mehta, MD

      Affiliations

    • Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Gösta B. Pettersson, MD, PhD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Eugene H. Blackstone, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
    • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio

Received 9 May 2008 ,Revised 11 August 2008 ,Accepted 26 October 2008.

  • Image Result

    Distribution of differences in aTLC versus pTLC by diagnosis. PAH, Pulmonary arterial hypertension; IPF, idiopathic pulmonary fibrosis; aTLC, actual total lung capacity; pTLC, predicted total lung cap

    Distribution of differences in aTLC versus pTLC by diagnosis. PAH, Pulmonary arterial hypertension; IPF, idiopathic pulmonary fibrosis; aTLC, actual total lung capacity; pTLC, predicted total lung capacity.

  • Image Result
    Cumulative distribution of donor-to-recipient TLC according to diagnosis. A, Donor-to-recipient pTLCRatio. B, Donor-to-recipient aTLCRatio. IPF, Idiopathic pulmonary fibrosis; pTLCRatio, donor-to-reci

    Cumulative distribution of donor-to-recipient TLC according to diagnosis. A, Donor-to-recipient pTLCRatio. B, Donor-to-recipient aTLCRatio. IPF, Idiopathic pulmonary fibrosis; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.

  • Image Result
    Overall unadjusted survival by terciles of donor-to-recipient pTLCRatio. Symbols represent deaths. Vertical bars represent 68% confidence limits equivalent to ± 1 standard error. Numbers in parenthese

    Overall unadjusted survival by terciles of donor-to-recipient pTLCRatio. Symbols represent deaths. Vertical bars represent 68% confidence limits equivalent to ± 1 standard error. Numbers in parentheses represent patients remaining at risk (P [log-rank] = .4). o = patients with largest 15% of pTLCRatio. • = patients with the middle 70% of pTLCRatio. □ = patients with the smallest 15% of pTLCRatio.

  • Image Result
    Unadjusted survival in patients with emphysema stratified by donor-to-recipient aTLCRatio. o = patients with extreme values of aTLCRatio (n = 44). □ = the 70% of patients with more typical values (n =

    Unadjusted survival in patients with emphysema stratified by donor-to-recipient aTLCRatio. o = patients with extreme values of aTLCRatio (n = 44). □ = the 70% of patients with more typical values (n = 108). Format is as in Figure 3. P (Wilcoxon) = .01.

  • Image Result
    Predicted mean FEV1% after lung transplantation for emphysema from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves

    Predicted mean FEV1% after lung transplantation for emphysema from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves represent specific values of donor-to-recipient aTLCRatio. FEV1%, Forced expiratory volume in 1 second; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.

  • Image Result
    Predicted mean FEV1% after lung transplantation for IPF from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves repres

    Predicted mean FEV1% after lung transplantation for IPF from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves represent specific values of donor-to-recipient aTLCRatio. FEV1%, Forced expiratory volume in 1 second; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.

  • Image Result
    Predicted mean FEV1% after lung transplantation for bronchiectasis from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual cu

    Predicted mean FEV1% after lung transplantation for bronchiectasis from multivariable model of Table 4. A, Individual curves represent specific values of donor-to-recipient pTLCRatio. B, Individual curves represent specific values of donor-to-recipient aTLCRatio. FEV1%, Forced expiratory volume in 1 second; pTLCRatio, donor-to-recipient predicted total lung capacity ratio; aTLCRatio, donor-to-recipient actual total lung capacity ratio.

  • Image Result
    Number of patients with spirometry measurements available at and beyond various time points, and number of spirometry measurements available for analysis (black bars, spirometry measurements; grey bar

    Number of patients with spirometry measurements available at and beyond various time points, and number of spirometry measurements available for analysis (black bars, spirometry measurements; grey bars, patients).

 Supported in part by the Kenneth Gee and Paula Shaw, PhD, Chair in Heart Research.

PII: S0022-5223(08)01750-9

doi: 10.1016/j.jtcvs.2008.10.024

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5 , Pages 1234-1240.e1 , May 2009